TABLE 3

Percent (%) inhibition of human liver microsomal metabolism of bortezomib using monoclonal antibodies (mAbs) and chemical inhibitors


P450 Isoform

% Inhibition of Bortezomib Metabolisma
Inhibitory mAbs
Chemical Inhibition
1A2 18.0 15.8
2C9 5.4 13.6
2C19 23.0 33.5
2D6 6.6 23.4
3A4
79.0
69.8
  • a Relative contribution of P450.